Table 4.
Gastric and esophageal cancer biomarker testing methods and algorithms (HER2)
| Characteristic, n = 54 | No. % |
|---|---|
| Methods* and multimethod algorithms† | |
| Concurrent HER2 FISH and IHC | 22 (41) |
| HER2 IHC, reflex test‡ to FISH | 21 (39) |
| Reflex test when result = IHC2+ | 6 (29) |
| Reflex test when result = IHC0, 1+ and 2+ | 6 (29) |
| Reflex test when result = IHC1+ and 2+ | 3 (14) |
| Reflex test when result = IHC2+ and 3+ | 3 (14) |
| Reflex test when result = IHC0, 1+, 2+, and 3+ | 2 (9) |
| Reflex test when result = IHC0 and 2+ | 1 (5) |
| HER2 FISH | 7 (13) |
| Concurrent HER2 CISH and FISH | 1 (2) |
| Concurrent HER2 CISH and IHC | 1 (2) |
| Concurrent HER2 IHC and SISH | 1 (2) |
| HER2 SISH | 1 (2) |
* Method, type of technology for testing a biomarker. Italicized choices represent various algorithms for reflexing to FISH test based on IHC results (0, 1+, 2+ and/or 3+). CISH = chromogenic in situ hybridization; FISH = fluorescence in situ hybridization; HER2 = human epidermal growth factor receptor 2; IHC = immunohistochemistry; SISH = silver in situ hybridization.
† Multimethod algorithm, a sequence of methods for testing one biomarker, when multiple methods are used.
‡ Reflex testing, confirming equivocal or borderline results by another method.